ALPHA LIPOTENE - Trademark Details
Status: 606 - Abandoned - No Statement Of Use Filed
Serial Number
74641832
Word Mark
ALPHA LIPOTENE
Status
606 - Abandoned - No Statement Of Use Filed
Status Date
1998-08-21
Filing Date
1995-03-03
Mark Drawing
1000 - Typeset: Word(s)/letter(s)/number(s)
Typeset
Published for Opposition Date
1996-05-28
Attorney Name
Law Office Assigned Location Code
L50
Employee Name
SMITH, LAURA
Statements
Goods and Services
pharmaceutical preparations for the treatment of neurological diseases and of polyneuropathy
Classification Information
International Class
5 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
8 - Abandoned
Class Status Date
1999-08-04
Primary Code
005
Correspondences
Name
Robert G. Weilacher
Address
Please log in with your Justia account to see this address.
Trademark Events
| Event Date | Event Description |
| 1995-07-21 | ASSIGNED TO EXAMINER |
| 1995-08-01 | NON-FINAL ACTION MAILED |
| 1996-02-01 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 1996-03-06 | EXAMINER'S AMENDMENT MAILED |
| 1996-03-11 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 1996-04-26 | NOTICE OF PUBLICATION |
| 1996-05-28 | PUBLISHED FOR OPPOSITION |
| 1996-08-20 | NOA MAILED - SOU REQUIRED FROM APPLICANT |
| 1997-02-05 | EXTENSION 1 FILED |
| 1997-03-15 | EXTENSION 1 GRANTED |
| 1997-07-21 | EXTENSION 2 FILED |
| 1997-08-12 | EXTENSION 2 GRANTED |
| 1998-02-09 | EXTENSION 3 FILED |
| 1998-03-21 | EXTENSION 3 GRANTED |
| 1998-10-23 | ABANDONMENT - NO USE STATEMENT FILED |
